Title : Mammalian target of rapamycin signaling and autophagy: roles in lymphangioleiomyomatosis therapy.

Pub. Date : 2010 Feb

PMID : 20160148






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In the year 2000, TSC2 gene mutations were found in LAM cells; in 2001 the tuberous sclerosis complex (TSC) genes were discovered to regulate cell size in Drosophila via the kinase TOR (target of rapamycin); and in 2008 the results were published of a clinical trial of rapamycin, a specific inhibitor of TOR, in patients with TSC and LAM with renal angiomyolipomas. Sirolimus Target of rapamycin Drosophila melanogaster